Adaptimmune Therapeutics
ADAP
#9234
Rank
$73.42 M
Marketcap
$0.28
Share price
4.45%
Change (1 day)
-75.90%
Change (1 year)

Adaptimmune Therapeutics (ADAP) Fails to deliver data

Key failure to deliver metrics for Adaptimmune Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Adaptimmune Therapeutics (ADAP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Adaptimmune Therapeutics (ADAP) - since 2015

Volume in USD (price x number of shares), data since 2015

Adaptimmune Therapeutics (ADAP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025$0.07 M-86.26%
2024$0.57 M-86.57%
2023$4.31 M424.88%
2022$0.82 M-74.5%
2021$3.22 M-92.83%
2020$44.92 M883.34%
2019$4.56 M-18.66%
2018$5.61 M202.64%
2017$1.85 M182.01%
2016$0.65 M-91.71%
2015$7.93 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
$7.51 M$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA
$0 M$0.14 M๐Ÿ‡บ๐Ÿ‡ธ USA
$2.99 M$6.65 M๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$3.75 M$15.17 M๐Ÿ‡บ๐Ÿ‡ธ USA